← Leaderboards
Thomas F Conway
Therapyx, Inc.
$4,515,092
Attributed
$4,515,092
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1000K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,515,092 · 5
By mechanism
R44$3,905,130 · 2
R43$609,962 · 3
Top collaborators
No co-investigators on record.
Most similar at Therapyx, Inc.
Same institution · by research overlap
- Dominick Auci$10,425,397
- Qiang Lou$808,517
- Dominick L Auci$1,748,998
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseT-LymphocyteCd4 Positive T LymphocytesDrug Delivery SystemsDoseDesignSeveritiesQuality Of LifeSiteDisease RemissionOralPre-ClinicalS DiseaseSerumDisease ModelMonitorInflammationCrohn&AposAdverse EffectsInflammatory Bowel DiseasesCytokineLifeNanoparticleMorbidity - Disease Rate
Grant awards (8)
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$999,998
R44 · FY2012 · AI · contact PI
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$999,998
R44 · FY2011 · AI · contact PI
Co-encapsulation of IroN and IL-12 as an Extra-intestinal E. coli Vaccine.$292,501
R43 · FY2008 · AI · contact PI
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$172,500
R43 · FY2008 · AI · contact PI
TUMOR IMMUNOTHERAPY WITH BIODEGRADABLE MICROSPHERES$629,093
R44 · FY2006 · CA · contact PI
Treatment of Type 2 Diabetes with Oral Administration of Nanoencapsulated GLP-1$144,961
R43 · FY2006 · DK · contact PI
TUMOR IMMUNOTHERAPY WITH BIODEGRADABLE MICROSPHERES$636,960
R44 · FY2005 · CA
TUMOR IMMUNOTHERAPY WITH BIODEGRADABLE MICROSPHERES$639,081
R44 · FY2004 · CA